CMV-specific TCR-transgenic T cells for immunotherapy

Journal of Immunology

Volumn 183, Issue 10, 2009, Pages 6819-6830

  Schub, Andrea ^a   Schuster, Ingrid G ^a   Hammerschmidt, Wolfgang ^a   Moosmann, Andreas ^a,b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

ADOPTIVE TRANSFER; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOMEGALOVIRUS; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFER; LYMPHOCYTOTOXICITY; MOLECULAR CLONING; PRIORITY JOURNAL; T LYMPHOCYTE;

CD8-POSITIVE T-LYMPHOCYTES; CLONE CELLS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERFERON-GAMMA; INTERLEUKIN-2; PHOSPHOPROTEINS; RECEPTORS, ANTIGEN, T-CELL; TRANSDUCTION, GENETIC; TRANSGENES; VIRAL MATRIX PROTEINS;

EID: 77954233293     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902233     Document Type: Article

References (54)

1. Boeckh, M., W. Leisenring, S. R. Riddell, R. A. Bowden, M. L. Huang, D. Myerson, T. Stevens-Ayers, M. E. Flowers, T. Cunningham, and L. Corey. 2003. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 101: 407-414.
2. Reusser, P., S. R. Riddell, J. D. Meyers, and P. D. Greenberg. 1991. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78: 1373-1380.
3. Li, C. R., P. D. Greenberg, M. J. Gilbert, J. M. Goodrich, and S. R. Riddell. 1994. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 83: 1971-1979.
4. Hebart, H., S. Daginik, S. Stevanovic, U. Grigoleit, A. Dobler, M. Baur, G. Rauser, C. Sinzger, G. Jahn, J. Loeffler, et al. 2002. Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-γ-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation. Blood 99: 3830-3837.
5. + T-cell immune recovery after allogeneic stem cell transplantation. Bone Marrow Transplant. 39: 293-299.
6. Riddell, S. R., K. S. Watanabe, J. M. Goodrich, C. R. Li, M. E. Agha, and P. D. Greenberg. 1992. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257: 238-241.
7. Einsele, H., E. Roosnek, N. Rufer, C. Sinzger, S. Riegler, J. Loffler, U. Grigoleit, A. Moris, H. G. Rammensee, L. Kanz, et al. 2002. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 99: 3916-3922.
8. Peggs, K. S., S. Verfuerth, A. Pizzey, N. Khan, M. Guiver, P. A. Moss, and S. Mackinnon. 2003. Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet 362: 1375-1377.
9. Cobbold, M., N. Khan, B. Pourgheysari, S. Tauro, D. McDonald, H. Osman, M. Assenmacher, L. Billingham, C. Steward, C. Crawley, et al. 2005. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J. Exp. Med. 202: 379-386.
10. Moss, P., and A. Rickinson. 2005. Cellular immunotherapy for viral infection after HSC transplantation. Nat. Rev. Immunol. 5: 9-20.
11. Borysiewicz, L. K., S. Graham, J. K. Hickling, P. D. Mason, and J. G. Sissons. 1988. Human cytomegalovirus-specific cytotoxic T cells: their precursor frequency and stage specificity. Eur. J. Immunol. 18: 269-275.
12. + T lymphocytes in healthy seropositive donors. J. Virol. 74: 8140-8150.
13. Boeckh, M., and W. G. Nichols. 2004. The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy. Blood 103: 2003-2008.
14. Dembic, Z., W. Haas, S. Weiss, J. McCubrey, H. Kiefer, H. von Boehmer, and M. Steinmetz. 1986. Transfer of specificity by murine α and β T-cell receptor genes. Nature 320: 232-238. (Pubitemid 16040238)
15. Clay, T. M., M. C. Custer, J. Sachs, P. Hwu, S. A. Rosenberg, and M. I. Nishimura. 1999. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity. J. Immunol. 163: 507-513.
16. Schumacher, T. N. 2002. T-cell-receptor gene therapy. Nat. Rev. Immunol. 2: 512-519.
17. Stauss, H. J., M. Cesco-Gaspere, S. Thomas, D. P. Hart, S. A. Xue, A. Holler, G. Wright, M. Perro, A. M. Little, C. Pospori, J. King, and E. C. Morris. 2007. Monoclonal T-cell receptors: new reagents for cancer therapy. Mol. Ther. 15: 1744-1750.
18. Morgan, R. A., M. E. Dudley, J. R. Wunderlich, M. S. Hughes, J. C. Yang, R. M. Sherry, R. E. Royal, S. L. Topalian, U. S. Kammula, N. P. Restifo, et al. 2006. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314: 126-129.
19. Wills, M. R., A. J. Carmichael, K. Mynard, X. Jin, M. P. Weekes, B. Plachter, and J. G. Sissons. 1996. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J. Virol. 70: 7569-7579.
20. + T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202: 673-685.
21. +-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J. Virol. 77: 5226-5240.
22. + T cells by mini-EBV-transformed B cell lines. Eur. J. Immunol. 35: 2110-2121.
23. + T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype. J. Infect. Dis. 185: 1025-1034.
24. + T cells following allogeneic hemopoietic stem cell transplantation. Blood 102: 3427-3438.
25. Trautmann, L., M. Rimbert, K. Echasserieau, X. Saulquin, B. Neveu, J. Dechanet, V. Cerundolo, and M. Bonneville. 2005. Selection of T cell clones expressing high-affinity public TCRs within human cytomegalovirus-specific CD8 T cell responses. J. Immunol. 175: 6123-6132.
26. + T cell populations specific for persistent DNA viruses. J. Exp. Med. 202: 1349-1361.
27. Heemskerk, M. H., R. S. Hagedoorn, M. A. van der Hoorn, L. T. van der Veken, M. Hoogeboom, M. G. Kester, R. Willemze, and J. H. Falkenburg. 2007. Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex. Blood 109: 235-243.
28. + T cell repertoire focusing and selection of highaffinity clones into memory following primary infection with a persistent human virus: human cytomegalovirus. J. Immunol. 179: 3203-3213.
29. Brennan, R. M., J. J. Miles, S. L. Silins, M. J. Bell, J. M. Burrows, and S. R. Burrows. 2007. Predictable αβ T-cell receptor selection toward an HLA-B* 3501-restricted human cytomegalovirus epitope. J. Virol. 81: 7269-7273.
30. + T cell responses to cytomegalovirus and EBV. J. Immunol. 181: 7853-7862.
31. Weekes, M. P., M. R. Wills, K. Mynard, A. J. Carmichael, and J. G. Sissons. 1999. The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo. J. Virol. 73: 2099-2108.
32. Moosmann, A., N. Khan, M. Cobbold, C. Zentz, H. J. Delecluse, G. Hollweck, A. D. Hislop, N. W. Blake, D. Croom-Carter, B. Wollenberg, et al. 2002. B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells. Blood 100: 1755-1764.
33. Wiesner, M., C. Zentz, C. Mayr, R. Wimmer, W. Hammerschmidt, R. Zeidler, and A. Moosmann. 2008. Conditional immortalization of human B cells by CD40 ligation. PLoS ONE 3: e1464.
34. Heemskerk, M. H., M. Hoogeboom, R. A. de Paus, M. G. Kester, M. A. van der Hoorn, E. Goulmy, R. Willemze, and J. H. Falkenburg. 2003. Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved α joining region. Blood 102: 3530-3540.
35. Roth, M. E., M. J. Lacy, L. K. McNeil, and D. M. Kranz. 1989. Analysis of T cell receptor transcripts using the polymerase chain reaction. BioTechniques 7: 746-754. (Pubitemid 19212400)
36. Steinle, A., C. Reinhardt, P. Jantzer, and D. J. Schendel. 1995. In vivo expansion of HLA-B35 alloreactive T cells sharing homologous T cell receptors: evidence for maintenance of an oligoclonally dominated allospecificity by persistent stimulation with an autologous MHC/peptide complex. J. Exp. Med. 181: 503-513.
37. Zhou, D., R. Srivastava, V. Grummel, S. Cepok, H. P. Hartung, and B. Hemmer. 2006. High throughput analysis of TCR-beta rearrangement and gene expression in single T cells. Lab. Invest. 86: 314-321.
38. Lefranc, M. P. 2003. IMGT databases, web resources and tools for immunoglobulin and T cell receptor sequence analysis: http://imgt.cines.fr. Leukemia 17: 260-266.
39. Engels, B., H. Cam, T. Schuler, S. Indraccolo, M. Gladow, C. Baum, T. Blankenstein, and W. Uckert. 2003. Retroviral vectors for high-level transgene expression in T lymphocytes. Hum. Gene Ther. 14: 1155-1168.
40. Sommermeyer, D., J. Neudorfer, M. Weinhold, M. Leisegang, B. Engels, E. Noessner, M. H. Heemskerk, J. Charo, D. J. Schendel, T. Blankenstein, H. Bernhard, and W. Uckert. 2006. Designer T cells by T cell receptor replacement. Eur. J. Immunol. 36: 3052-3059.
41. Leisegang, M., B. Engels, P. Meyerhuber, E. Kieback, D. Sommermeyer, S. A. Xue, S. Reuss, H. Stauss, and W. Uckert. 2008. Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette. J. Mol. Med. 86: 573-583.
42. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712. (Pubitemid 129515761)
43. Rizzieri, D. A., P. Dev, G. D. Long, C. Gasparetto, K. M. Sullivan, M. Horwitz, J. Chute, and N. J. Chao. 2009. Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3-6/6 HLA matched donors. Bone Marrow Transplant. 43: 327-333.
44. Haque, T., G. M. Wilkie, M. M. Jones, C. D. Higgins, G. Urquhart, P. Wingate, D. Burns, K. McAulay, M. Turner, C. Bellamy, et al. 2007. Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood 110: 1123-1131.
45. Kleihauer, A., U. Grigoleit, H. Hebart, A. Moris, P. Brossart, A. Muhm, S. Stevanovic, H. G. Rammensee, C. Sinzger, S. Riegler, et al. 2001. Ex vivo generation of human cytomegalovirus-specific cytotoxic T cells by peptidepulsed dendritic cells. Br. J. Haematol. 113: 231-239.
46. Szmania, S., A. Galloway, M. Bruorton, P. Musk, G. Aubert, A. Arthur, H. Pyle, N. Hensel, N. Ta, L. Lamb, Jr., et al. 2001. Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers. Blood 98: 505-512.
47. Kondo, E., Y. Akatsuka, K. Kuzushima, K. Tsujimura, S. Asakura, K. Tajima, Y. Kagami, Y. Kodera, M. Tanimoto, Y. Morishima, and T. Takahashi. 2004. Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles. Blood 103: 630-638.
48. Arstila, T. P., A. Casrouge, V. Baron, J. Even, J. Kanellopoulos, and P. Kourilsky. 1999. A direct estimate of the human αβ T cell receptor diversity. Science 286: 958-961.
49. van der Veken, L. T., R. S. Hagedoorn, M. M. van Loenen, R. Willemze, J. H. Falkenburg, and M. H. Heemskerk. 2006. αβ T-cell receptor engineered γδ T cells mediate effective antileukemic reactivity. Cancer Res. 66: 3331-3337.
50. Van Lent, A. U., M. Nagasawa, M. M. van Loenen, R. Schotte, T. N. Schumacher, M. H. Heemskerk, H. Spits, and N. Legrand. 2007. Functional human antigen-specific T cells produced in vitro using retroviral T cell receptor transfer into hematopoietic progenitors. J. Immunol. 179: 4959-4968.
51. Uckert, W., and T. N. Schumacher. 2009. TCR transgenes and transgene cassettes for TCR gene therapy: status in 2008. Cancer Immunol. Immunother. 58: 809-822.
52. Heemskerk, M. H., M. Hoogeboom, R. Hagedoorn, M. G. Kester, R. Willemze, and J. H. Falkenburg. 2004. Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer. J. Exp. Med. 199: 885-894.
53. van Loenen, M. M., R. S. Hagedoorn, M. G. Kester, M. Hoogeboom, R. Willemze, J. H. Falkenburg, and M. H. Heemskerk. 2009. Kinetic preservation of dual specificity of coprogrammed minor histocompatibility antigen-reactive virus-specific T cells. Cancer Res. 69: 2034-2041.
54. Kieback, E., J. Charo, D. Sommermeyer, T. Blankenstein, and W. Uckert. 2008. A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer. Proc. Natl. Acad. Sci. USA 105: 623-628.